Hauʻoli mākou e hui pū me nā alakaʻi ʻoihana ma CPHI South East Asia 2025, mai Iulai 16 a 18 ma MITEC ma Kuala Lumpur. Aia ka hanana ma luna o 15,000 square meters a e hōʻike ʻia ma kahi o 400 mau mea hōʻike. ʻOi aku ma mua o 8,000 poʻe loea e manaʻo ʻia e hele, me 60+ seminars a me nā ʻaha kūkā e pili ana i nā ʻano ʻoihana o kēia manawa, nā ʻenehana hou, a me nā hoʻomohala hoʻoponopono. He manawa kūpono loa ia no ka launa pū ʻana a me ka hui pū ʻana ma waena o ke kaulahao lako lāʻau.

E pili ana iā JYMed
 
ʻO JYMed kahi hui lāʻau lapaʻau e pili ana i ka peptide e ʻike nui ana i ka noiʻi, hoʻomohala, hana, a me ke kālepa. Hāʻawi mākou i nā lawelawe CDMO i hoʻopili piha ʻia i nā mea kūʻai lāʻau lapaʻau, cosmetic, a me nā holoholona holoholona ma ka honua holoʻokoʻa.

Loaʻa kā mākou kōpili i kahi ākea o nā API peptide. Ua hoʻopau maikaʻi nā huahana Flagship e like me Semaglutide a me Tirzepatide i nā faila DMF US FDA.

ʻO kā mākou hui, ʻo Hubei JXBio, holo i nā laina hana peptide API holomua i kūkulu ʻia e hoʻokō i nā kūlana cGMP mai ka US FDA a me ka NMPA o Kina. Aia i loko o ka hale he 10 nui a me nā laina hana hoʻokele pilote a kākoʻo ʻia e kahi ʻōnaehana hoʻokele maikaʻi maikaʻi (QMS) a me nā protocol Environmental Health and Safety (EHS).

Ua hala ʻo JXBio i nā mākaʻikaʻi GMP mai ka US FDA a me ka NMPA o Kina. Haʻaheo mākou i ka ʻike ʻia ʻana e nā hoa hana lāʻau lapaʻau honua no ka maikaʻi o ka maikaʻi, palekana, a me ka hoʻokō kaiapuni.

HANA NUI

Kāhea iā mā˚ou
No nā nīnau, e ʻoluʻolu e kelepona mai:
● API honua a me nā nīnau hoʻonani:+86-150-1352-9272
● Hoʻopaʻa inoa API a me nā lawelawe CDMO (US & EU):+86-158-1868-2250
● leka uila: jymed@jymedtech.com
● Helu helu:Nā Papa 8 & 9, Hale 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen, Kina.